يحاول ذهب - حر
Innovations in Urological Imaging: Transforming Patient Care in India
BioSpectrum India Dec 2024
|Bio Spectrum
Despite advancements in urological imaging, challenges persist in India, particularly regarding cost and accessibility. Government initiatives and public-private partnerships should expand access to imaging facilities. Continued research investment is crucial for developing cost-effective solutions.
-

Dr Vinay Prabhu, Consultant Department of Radiology, Ramaiah Memorial Hospital, Bangalore
The landscape of urological care in India is undergoing a significant transformation, driven by cutting-edge innovations in medical imaging. These advancements are revolutionising the diagnosis, treatment, and management of urological conditions, offering new hope to millions nationwide.
Urologic cancers, including bladder, kidney, prostate, testicular, and urethral cancers, present unique challenges in detection and treatment.
According to the Global Cancer Observatory (GLOBOCAN), India ranked third globally in cancer incidence for 2020, with projections indicating a 57.5 per cent increase in cancer cases by 2040, reaching an estimated 2.08 million cases. In response, integrating state-of-the-art imaging technologies is proving transformative in urology. These innovations enhance the ability to detect and characterise urological malignancies, paving the way for precise, personalised treatment strategies.
Multiparametric MRI: A Paradigm Shift in Prostate Cancer Detection
One of the most significant breakthroughs has been the adoption of multiparametric MRI (mpMRI) for prostate cancer diagnosis. Prostate cancer ranks as the third leading cancer site among males in India. mpMRI has emerged as a superior imaging modality compared to standard MRI for prostate cancer evaluation. While standard MRI primarily provides anatomical details, mpMRI incorporates a combination of imaging techniques, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCE). These functional imaging techniques assess tissue characteristics such as cellular density and vascularity, enabling mpMRI to achieve higher sensitivity and specificity in detecting clinically significant prostate cancer.
هذه القصة من طبعة BioSpectrum India Dec 2024 من Bio Spectrum.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Bio Spectrum

Bio Spectrum
India's Pharma Reforms Target Global Credibility
The Indian government has introduced several measures to simplify drug approvals and support innovation.
9 mins
October 2025

Bio Spectrum
How Waste Management Strategies Can Transform Indian Pharma Manufacturing
Sustainability will be a key success factor as India's pharmaceutical industry enters its next stage of expansion.
7 mins
October 2025

Bio Spectrum
IASST synthesises new compound to combat aggressive breast cancer
A newly designed nitro-substituted organoselenium compound by Guwahati-based Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology (DST), can reduce the invasiveness of aggressive triplenegative breast cancer cells by modulating various Se Se signalling pathways.
1 min
October 2025
Bio Spectrum
DPIIT signs MoU with Pfizer to strengthen healthcare innovation ecosystem
In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has signed a Memorandum of Understanding (MoU) with Pfizer Limited.
1 min
October 2025

Bio Spectrum
WHO unveils updated guideline on HIV service delivery
WHO has released an updated guideline to support integrated HIV service delivery, promote long-term adherence to antiretroviral therapy (ART), and improve the overall health and well-being of people living with HIV.
1 min
October 2025
Bio Spectrum
Scientists in Kolkata explore therapeutic potential of accessory proteins
A hidden protein that protects our cells from mechanical stress could provide a new direction to therapeutic strategies for diseases where protein stability under force is compromised like heart muscle disease or genetic disorders called laminopathies.
1 min
October 2025

Bio Spectrum
US FDA advances rare disease drug development
The US Food and Drug Administration (FDA) has introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.
1 min
October 2025
Bio Spectrum
WHO updates list of essential medicines to include key cancer, diabetes treatments
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLC), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.
1 min
October 2025
Bio Spectrum
Agilent's MMR IHC Panel pharmDx (Dako Omnis) receives European IVDR Certification
Agilent Technologies Inc. has announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer.
1 min
October 2025
Bio Spectrum
Aodh Lifesciences gets support from TDB to redefine pneumonia treatment
The Technology Development Board (TDB), Department of Science and Technology, Government of India, has extended support to Aodh Lifesciences, a startup based in Hyderabad, for development of Indigenous Antibiotic Nebulisation Suspension for Pneumonia (AONEUM-04) and Antimicrobial Resistance (AMR).
1 min
October 2025
Listen
Translate
Change font size